Cipla inks pact with Acebright group to build respiratory biz in China

Cipla’s entry into China’s branded respiratory segment is in line with its pursuit to build a global respiratory franchise. The segment alone contributed about one-fifth to Cipla’s sales of Rs 16,362 crore in FY19.

from Moneycontrol Business News https://ift.tt/2jHyX0h